NVAX
Novavax Inc
Price:  
14.02 
USD
Volume:  
8,523,902.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax Probability of Bankruptcy

The Probability of Bankruptcy of Novavax Inc (NVAX) is 38.57% . This number represents the probability that Novavax will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Novavax's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Novavax - ESG ratings

ESG ratings are directly linked to the cost of capital and Novavax's ability to raise funding, both of which can significantly affect the probability of Novavax Inc going bankrupt.

ESG Score 60.60
Environment Score 62.71
Social Score 82.13
Governance Score 36.96
Returns
Historical Returns (5 day) -2.78%
Historical Returns (MTD) -6.85%
Historical Returns (YTD) 191.67%
Historical Returns (13 week) 189.86%
Historical Returns (26 week) 146.05%
Historical Returns (52 week) 95.53%
Efficiency
Asset Turnover 0.61
Receiveable Turnover 14.85
Gross Margin 36.91%
Operating Margin -154.31%
Pretax Margin -154.80%
Net Margin -157.21%
Return on Asset (ROA) -24.56
Return on Equity (ROE) -111.14
Return on Investments (ROI) -55.01
Price Metrics
Market Cap (M) 1,968.69
Enterprise Value (M)
52 Week High 23.86
52 Week Low 3.54
Beta 2.58
Average Volume (10 day) 13.72
Average Volume (3 month) 11.43
Price / Earnings (P/E)
Price / Sales (P/S) 2.00
Earnings
EPS -3.20
Revenue CAGR (5 year) 95.67%
Risk
Current Ratio 0.90
Quick Ratio 0.64